AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
13:51
The interim Minister of Defense, Radu Miruţă, about the future government: "We have stated what the thresholds are for us to sit at the table, we will no longer vote for a government with PSD. PNL, USR, and UDMR no longer have a place in the same chamber with PSD."
13:50
The BNR launches a silver coin dedicated to Nicolae Tonitza, on the 140th anniversary of his birth. The coin is rectangular in shape and is worth 10 lei.
13:48
Major breakdown on the Berceni Pipeline: Sector 4 remains without hot water
13:43
Spontaneous protest in Arad, dozens of victims demand the recovery of their money or the delivery of the paid cars
13:35
Firefighter found shot in the IGSU unit in Mizil, investigation underway
See more news